Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects

in European Journal of Endocrinology
Restricted access


Hypomagnesemia and low erythrocyte magnesium content are both common findings in non-insulin-dependent diabetic subjects. Moreover, intracellular magnesium may play a crucial role in modulating B-cell response to glucose by interfering with potassium permeability. Eight elderly, moderately obese, non-insulin-dependent diabetic subjects were treated with either magnesium supplementation (3 g/day) to the diet or placebo. Both treatment schemes lasted 4 weeks and were separated by a 'wash-out' of 3 weeks. At the end of each treatment period, an iv glucose tolerance test (0.33 g/kg for 3 min) and an iv arginine (5 g) test were performed to determine the B- and A-cell responses. Dietary magnesium supplementation vs placebo produced a slight but significant decrease in basal plasma glucose (8.6 ± 0.3 vs 8.0 ± 0.1 mmol/l, p < 0.05) and an increase in acute insulin response after iv glucose (37.1 ± 2.3 vs −14.7 ±0.9 pmol · 1−1 · (10 min)−1, p < 0.01) and after iv arginine (151 ± 22 vs 81 ± 15 pmol · 1−1 · (10 min)−1, p < 0.01), respectively. Plasma glucagon levels were unaffected by chronic dietary magnesium supplementation as well under basal conditions as in response to arginine. Net increase in acute insulin response after iv glucose and after iv arginine was significantly correlated to the net increase in erythrocyte magnesium content after dietary magnesium supplementation. We conclude that magnesium administration may be a useful adjuvant to the classic hypoglycemic agents in the treatment of non-insulin-dependent diabetic subjects.


     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 373 131 13
Full Text Views 103 0 0
PDF Downloads 68 0 0